CA2870823C - A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) - Google Patents

A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) Download PDF

Info

Publication number
CA2870823C
CA2870823C CA2870823A CA2870823A CA2870823C CA 2870823 C CA2870823 C CA 2870823C CA 2870823 A CA2870823 A CA 2870823A CA 2870823 A CA2870823 A CA 2870823A CA 2870823 C CA2870823 C CA 2870823C
Authority
CA
Canada
Prior art keywords
bone
cavities
osteoporosis
vitamin
metabolic syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2870823A
Other languages
English (en)
French (fr)
Other versions
CA2870823A1 (en
Inventor
Villorij Ivanovich STRUKOV
Olga JHONES
Evgenij Nikolaevich KRUTIAKOV
Konstantin Gennad'evich ELISTRATOV
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parafarm OOO
Original Assignee
Parafarm OOO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parafarm OOO filed Critical Parafarm OOO
Publication of CA2870823A1 publication Critical patent/CA2870823A1/en
Application granted granted Critical
Publication of CA2870823C publication Critical patent/CA2870823C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
CA2870823A 2012-04-19 2012-08-21 A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) Active CA2870823C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
RU2012115654 2012-04-19
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (2)

Publication Number Publication Date
CA2870823A1 CA2870823A1 (en) 2013-10-24
CA2870823C true CA2870823C (en) 2017-10-03

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2870823A Active CA2870823C (en) 2012-04-19 2012-08-21 A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome)

Country Status (17)

Country Link
US (1) US9827273B2 (enExample)
EP (1) EP2845598B1 (enExample)
JP (1) JP6286417B2 (enExample)
CN (1) CN104736161B (enExample)
AU (1) AU2012377476B2 (enExample)
BR (1) BR112014025990B1 (enExample)
CA (1) CA2870823C (enExample)
DK (1) DK2845598T3 (enExample)
EA (1) EA026533B1 (enExample)
ES (1) ES2616035T3 (enExample)
IL (1) IL235169B (enExample)
IN (1) IN2014DN09780A (enExample)
LT (1) LT2845598T (enExample)
PL (1) PL2845598T3 (enExample)
RU (1) RU2497533C1 (enExample)
UA (1) UA111536C2 (enExample)
WO (1) WO2013157982A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины
EP4268688A4 (en) * 2021-04-13 2024-09-04 Samsung Electronics Co., Ltd. Cooking apparatus and control method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
JP2007525953A (ja) * 2003-06-06 2007-09-13 ワイス 骨リモデリングを調節する物質を同定するための方法および材料、ならびにそれによって同定された物質
JP5509504B2 (ja) * 2008-02-13 2014-06-04 ディーエスエム アイピー アセッツ ビー．ブイ． 骨塩密度を改善し、骨粗鬆症を治療するための２５−ヒドロキシ−ビタミンｄ３とビタミンｄ３の併用
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
EA026533B1 (ru) 2017-04-28
RU2497533C1 (ru) 2013-11-10
ES2616035T3 (es) 2017-06-09
EP2845598B1 (en) 2017-01-04
AU2012377476B2 (en) 2017-10-05
EA201401155A1 (ru) 2015-05-29
WO2013157982A1 (ru) 2013-10-24
IL235169B (en) 2019-10-31
CN104736161B (zh) 2021-07-06
CN104736161A (zh) 2015-06-24
BR112014025990A2 (pt) 2017-06-27
JP6286417B2 (ja) 2018-02-28
US9827273B2 (en) 2017-11-28
AU2012377476A1 (en) 2014-12-11
JP2015516974A (ja) 2015-06-18
CA2870823A1 (en) 2013-10-24
EP2845598A4 (en) 2015-10-28
UA111536C2 (uk) 2016-05-10
EP2845598A1 (en) 2015-03-11
IL235169A0 (en) 2014-12-31
BR112014025990B1 (pt) 2021-02-17
DK2845598T3 (en) 2017-04-10
PL2845598T3 (pl) 2017-07-31
AU2012377476A8 (en) 2014-12-18
US20150224150A1 (en) 2015-08-13
IN2014DN09780A (enExample) 2015-07-31
LT2845598T (lt) 2017-02-27

Similar Documents

Publication Publication Date Title
CA2870823C (en) A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome)
JP2015516974A5 (ja) 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤
AU2012377478B2 (en) Preparation and method for the prophylaxis and treatment of osteoporosis and bone fractures
AU2017203767B2 (en) Method for filling bone cavity formations with calcium
KR102491748B1 (ko) 정형외과적 질병의 치료를 위한 조성물 및 방법
BR112017007364B1 (pt) Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico
US20190381072A1 (en) Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
EA028560B1 (ru) Способ и препарат для лечения артритов и артрозов
NZ619215B2 (en) Method for filling bone cavities with calcium

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20151215

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD

Year of fee payment: 12

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240910

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240910